Galapagos Nv's Comment on Sales, Marketing and Customers
The company operates in markets related to the pricing of European options and subscription rights, as well as in immunotherapy using CAR-T cells and cell therapy for diseases including cancer and dermatomyositis. It serves the pharmaceutical, biotechnology, and medical devices industries through contract research organizations (CROs). Key market segments include the European Union, Great Britain, and Japan for the drug Filgotinib, marketed under the brand name Jyseleca®. Regulatory oversight is provided by agencies such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). In 2024, the Jyseleca® business was transferred to AlfaSigma. AlfaSigma is identified as a customer in the company's filings.
Galapagos Nv’s Comment on Sales, Marketing and Customers
The company operates in markets related to the pricing of European options and subscription rights, as well as in immunotherapy using CAR-T cells and cell therapy for diseases including cancer and dermatomyositis. It serves the pharmaceutical, biotechnology, and medical devices industries through contract research organizations (CROs). Key market segments include the European Union, Great Britain, and Japan for the drug Filgotinib, marketed under the brand name Jyseleca®. Regulatory oversight is provided by agencies such as the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). In 2024, the Jyseleca® business was transferred to AlfaSigma. AlfaSigma is identified as a customer in the company's filings.
Sources:
Galapagos Nv’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Galapagos Nv’s corporate clients.
For your research, we’ve provided 9 tables on Galapagos Nv corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
97.2 %